Alexion expands Soliris recall; Brazil wants track-and-trace in place in 3 years;

> Alexion ($ALXN) has expanded its recall of two lots of its rare disease drug Soliris to the hospital and user level. Release

> The FDA says compounder Rx Formulation has voluntarily recalled its calcium gluconate injection because 2- to 3-millimeter, irregularly shaped floating matter was observed in an unused vial. Release

>  An inaugural meeting has been held for the Rx-360 Asia Working Group, an outgrowth of Rx-360, a consortia of pharmaceutical and biotech companies working toward enhancing the security of the pharmaceutical supply chain. Release

> Workers at Pfizer's ($PFE) plant in Newbridge in Ireland have until Jan. 20 to apply for voluntary redundancy before the company starts laying off 150 workers. Story

> Sri Lanka plans to set up a dedicated industrial zone to manufacture pharmaceutical products. Report

> India's smaller generic drugmakers are hoping for passage of the Small Manufacturer Protection Act of 2013, a piece of legislation that would allow the FDA to cut fees on small operations. Story

> The FDA has issued a proposed rule to require makers of antibacterial hand soaps and body washes to show they work better than plain soap at preventing illness and the spread of certain infections and that they are safe for long-term daily use. Announcement

And Finally... Brazil's drug regulator Anvisa is giving manufacturers three years to set up track-and-trace capabilities that will allow it to monitor drugs from plant to pharmacy. Story